Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for LEGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 521.32M
March 31, 2026 629.02M
December 31, 2025 723.60M
September 30, 2025 693.56M
June 30, 2025 647.50M
March 31, 2025 591.84M
December 31, 2024 623.45M
September 30, 2024 613.17M
June 30, 2024 632.61M
March 31, 2024 604.38M
December 31, 2023 589.93M
September 30, 2023 492.93M
June 30, 2023 516.59M
March 31, 2023 548.57M
Date Value
December 31, 2022 578.99M
September 30, 2022
June 30, 2022 453.67M
March 31, 2022 301.14M
December 31, 2021 351.66M
September 30, 2021 585.98M
June 30, 2021 533.21M
March 31, 2021 406.85M
December 31, 2020 122.27M
September 30, 2020 371.71M
June 30, 2020 371.86M
March 31, 2020 531.27M
December 31, 2019 410.58M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
AbbVie, Inc. 141.00B
Dianthus Therapeutics, Inc. 41.25M
Gilead Sciences, Inc. 37.62B
Ironwood Pharmaceuticals, Inc. 446.97M
Arbutus Biopharma Corp. 15.29M

Total Liabilities (Quarterly) Related Metrics